Double maintains 3 strategies that include EXEL - Exelixis, Inc.
Yahoo
A Relative Strength Rating upgrade for Arcutis Biotherapeutics shows improving technical performance. Will it continue?
SeekingAlpha
Upgrade alert: Exelixis (EXEL) moves to 'Buy' with a de-risked pipeline, strong financials, and breakthrough phase 3 results. See more analysis here.
Yahoo
EXEL surges 35.2% in three months as strong Cabometyx sales and zanzalintinib trial success fuel investor optimism.
Yahoo
AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.
Yahoo
Pfizer is slowly building a foundation that will help its business recover from recent headwinds. Encouraging developments on the clinical front should boost shares of cancer specialist Exelixis. Buying fractional shares is one way to apply this strategy, but it's also possible to find attractive corporations at already-affordable prices.
Yahoo
EXEL vs. ARGX: Which Stock Is the Better Value Option?
Current Value
$45.001 Year Return
Current Value
$45.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DAVA | -16.28% | $626.94M | -51.98% | 0.00% |
AIFU | -15.42% | $17.40M | +87.81% | 0.00% |
TXO | -11.50% | $825.05M | -29.00% | 15.77% |
LEGN | -10.82% | $7.31B | -18.12% | 0.00% |
BGFV | -9.93% | $32.35M | -48.35% | 0.00% |
SGC | -9.66% | $177.73M | -42.29% | 5.06% |
LITB | -9.04% | $24.26M | -71.62% | 0.00% |
STG | -8.65% | $38.79M | -3.01% | 0.00% |
AGI | -8.43% | $10.98B | +49.03% | 0.38% |
OPCH | -8.34% | $4.99B | +5.28% | 0.00% |
IMDX | -8.24% | $82.65M | -8.25% | 0.00% |
ATNI | -8.07% | $284.85M | -16.50% | 5.35% |
SMCI | -8.05% | $30.06B | -43.37% | 0.00% |
EXK | -7.82% | $1.58B | +12.40% | 0.00% |
GIFI | -7.77% | $114.38M | +13.53% | 0.00% |
WST | -7.70% | $16.47B | -31.22% | 0.36% |
HRMY | -7.42% | $1.97B | +3.03% | 0.00% |
ODP | -7.41% | $558.63M | -52.43% | 0.00% |
SAGE | -7.01% | $576.75M | -21.52% | 0.00% |
MKTX | -6.82% | $8.21B | +2.36% | 1.37% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MLN | -0.05% | $513.19M | 0.24% |
BILZ | 0.15% | $851.85M | 0.14% |
DBC | 0.17% | $1.27B | 0.87% |
MMIN | -0.18% | $322.53M | 0.3% |
HYD | -0.19% | $3.31B | 0.32% |
IBTH | -0.21% | $1.62B | 0.07% |
LMBS | 0.21% | $5.11B | 0.64% |
CMF | 0.23% | $3.50B | 0.08% |
BSMR | -0.29% | $258.51M | 0.18% |
IBMS | 0.31% | $89.61M | 0.18% |
COMT | -0.32% | $617.76M | 0.48% |
TFI | 0.36% | $3.21B | 0.23% |
IAGG | 0.42% | $10.49B | 0.07% |
SCHO | 0.45% | $10.98B | 0.03% |
COM | 0.48% | $210.86M | 0.72% |
PALL | -0.48% | $521.82M | 0.6% |
IBDQ | 0.61% | $2.96B | 0.1% |
GSG | 0.64% | $1.02B | 0.75% |
SIVR | 0.69% | $2.03B | 0.3% |
UGA | 0.85% | $76.33M | 0.97% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FBT | 33.50% | $1.02B | 0.54% |
PBE | 33.33% | $226.91M | 0.58% |
SMMV | 30.71% | $320.18M | 0.2% |
DVY | 30.46% | $20.13B | 0.38% |
CDC | 29.35% | $747.30M | 0.42% |
XMLV | 29.27% | $814.34M | 0.25% |
FTCS | 29.06% | $8.43B | 0.52% |
LGLV | 28.99% | $1.08B | 0.12% |
FDLO | 28.71% | $1.22B | 0.16% |
OUSA | 28.68% | $817.37M | 0.48% |
IXG | 28.67% | $526.39M | 0.41% |
MDIV | 28.66% | $451.37M | 0.75% |
XLF | 28.61% | $50.56B | 0.09% |
XPH | 28.56% | $150.58M | 0.35% |
SPLV | 28.40% | $7.63B | 0.25% |
FVD | 28.34% | $9.06B | 0.61% |
VFH | 28.25% | $12.55B | 0.09% |
DLN | 28.15% | $5.07B | 0.28% |
IYG | 28.12% | $1.84B | 0.39% |
IBB | 27.85% | $5.37B | 0.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -20.26% | $94.86M | 0.59% |
VIXY | -18.74% | $184.73M | 0.85% |
BTAL | -12.52% | $315.93M | 1.43% |
IVOL | -12.43% | $342.69M | 1.02% |
CTA | -10.78% | $1.08B | 0.76% |
TBLL | -8.95% | $2.12B | 0.08% |
SHYD | -8.36% | $331.91M | 0.35% |
FXE | -8.00% | $588.06M | 0.4% |
BILS | -7.15% | $3.80B | 0.1356% |
GBIL | -7.12% | $6.36B | 0.12% |
BAR | -6.35% | $1.11B | 0.1749% |
IAU | -6.23% | $47.13B | 0.25% |
SGOL | -6.22% | $5.21B | 0.17% |
OUNZ | -6.18% | $1.73B | 0.25% |
GLD | -6.09% | $100.92B | 0.4% |
AAAU | -6.03% | $1.56B | 0.18% |
PPLT | -5.89% | $1.69B | 0.6% |
SHYM | -5.75% | $355.86M | 0.35% |
GLDM | -5.60% | $15.88B | 0.1% |
XONE | -5.12% | $628.85M | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KRNT | 39.84% | $915.16M | +32.39% | 0.00% |
CIM | 35.20% | $1.14B | -2.75% | 10.50% |
FSP | 34.77% | $177.10M | +7.55% | 2.33% |
JAZZ | 34.64% | $6.81B | +6.07% | 0.00% |
GRMN | 33.04% | $41.94B | +30.61% | 1.46% |
CAKE | 31.51% | $3.18B | +69.99% | 1.69% |
PRAA | 31.45% | $644.06M | -22.22% | 0.00% |
RYAM | 31.27% | $299.82M | -17.01% | 0.00% |
V | 31.01% | $690.11B | +35.55% | 0.65% |
DT | 30.76% | $15.93B | +20.36% | 0.00% |
ADP | 30.66% | $124.14B | +29.79% | 1.97% |
BBU | 30.42% | $2.31B | +30.12% | 0.97% |
MA | 30.03% | $511.70B | +29.12% | 0.53% |
BRSP | 29.73% | $665.36M | -18.40% | 12.65% |
PAYO | 29.70% | $2.47B | +28.63% | 0.00% |
OMCL | 29.58% | $1.39B | +11.21% | 0.00% |
PRI | 28.96% | $8.78B | +12.19% | 1.46% |
D | 28.84% | $49.60B | +12.65% | 4.63% |
BRBR | 28.77% | $7.40B | +5.60% | 0.00% |
CWEN.A | 28.70% | $3.59B | +29.45% | 5.66% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MSIF | 0.05% | $773.71M | +36.92% | 7.56% |
CYRX | -0.06% | $376.53M | +6.83% | 0.00% |
ANIP | 0.06% | $1.43B | +2.88% | 0.00% |
HUM | -0.07% | $28.02B | -38.86% | 1.54% |
ABCL | -0.14% | $1.27B | +35.78% | 0.00% |
DAO | 0.17% | $275.90M | +140.33% | 0.00% |
LX | 0.20% | $932.12M | +304.02% | 2.60% |
IRWD | -0.20% | $125.56M | -88.64% | 0.00% |
VSA | 0.23% | $8.59M | -17.17% | 0.00% |
FUTU | 0.25% | $16.18B | +113.48% | 0.00% |
QRVO | 0.28% | $8.39B | -26.28% | 0.00% |
UAN | 0.29% | $942.70M | +15.34% | 8.02% |
WBTN | 0.30% | $1.28B | -50.77% | 0.00% |
HY | 0.30% | $754.78M | -37.62% | 3.34% |
BTG | -0.32% | $4.59B | +16.44% | 3.41% |
TEF | -0.32% | $29.35B | +18.72% | 6.32% |
ARHS | -0.37% | $1.33B | -41.33% | 0.00% |
MEOH | 0.37% | $2.29B | -32.62% | 2.19% |
CRVO | 0.37% | $62.75M | -54.74% | 0.00% |
NOC | -0.38% | $73.96B | +18.95% | 1.66% |